Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

vTv Therapeutics Inc. - Class A Common Stock (NQ:VTVT)

23.99 -0.93 (-3.73%)
Streaming Delayed Price Updated: 9:40 AM EST, Nov 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,419
Open 22.46
Bid (Size) 23.50 (100)
Ask (Size) 24.41 (100)
Prev. Close 24.92
Today's Range 22.45 - 23.99
52wk Range 12.62 - 26.99
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why AMD Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga

Performance

YTD
+76.8%
+76.8%
1 Month
+6.2%
+6.2%
3 Month
+64.1%
+64.1%
6 Month
+10.7%
+10.7%
1 Year
+71.4%
+71.4%

More News

Read More
VTV Therapeutics Inc-CL A (NASDAQ:VTVT) Reports Wider Q2 2025 Loss Amid Clinical-Stage Progress
Via Chartmill
This Couchbase Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
VTVT Stock Earnings: vTv Therapeutics Reported Results for Q2 2024
Via InvestorPlace
VTVT Stock Earnings: vTv Therapeutics Reported Results for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
FDA Lifts Clinical Hold On vTv Therapeutics' Phase 3 Diabetes Trial, Stock Surges
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Dow Edges Lower; Ventyx Biosciences Shares Plummet
Via Benzinga
Topics Stocks
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump
Via Benzinga
FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks
Via Benzinga
Nasdaq Gains 1%; McDonald's Posts Downbeat Results
Via Benzinga
Why Is LuxUrban Hotels (LUXH) Stock Down 12% Today?
Via InvestorPlace
Why Is vTv Therapeutics (VTVT) Stock Down 46% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
The Top 3 Healthcare Stocks to Buy on Weakness in 2024
Via InvestorPlace
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Why Is Diabetes Focused vTv Therapeutics Stock Trading Higher Today?
Via Benzinga
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares?
Via Investor's Business Daily

Frequently Asked Questions

Is vTv Therapeutics Inc. - Class A Common Stock publicly traded?
Yes, vTv Therapeutics Inc. - Class A Common Stock is publicly traded.
What exchange does vTv Therapeutics Inc. - Class A Common Stock trade on?
vTv Therapeutics Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for vTv Therapeutics Inc. - Class A Common Stock?
The ticker symbol for vTv Therapeutics Inc. - Class A Common Stock is VTVT on the Nasdaq Stock Market
What is the current price of vTv Therapeutics Inc. - Class A Common Stock?
The current price of vTv Therapeutics Inc. - Class A Common Stock is 23.99
When was vTv Therapeutics Inc. - Class A Common Stock last traded?
The last trade of vTv Therapeutics Inc. - Class A Common Stock was at 11/05/25 09:40 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.